Crossmark

Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis

Crossref DOI link: https://doi.org/10.1007/s00277-025-06305-1

Published Online: 2025-03-17

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jia, Yannan

Xia, Xinxin

Yang, Jun

Cai, Yu

Tong, Yin

Qiu, Huiying

Huang, Chongmei

Zhou, Kun

Zhang, Ying

Shen, Chang

Wan, Liping

Song, Xianmin
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-17
More Information

Article History

Received: 15 September 2024

Accepted: 4 March 2025

First Online: 17 March 2025

Declarations

:

: The study was approved by the institutional review committee of the ethics committee of Shanghai General Hospital. All patients gave written informed consent according to theHelsinki declaration.

: All patients gave written informed consent according to the Helsinki declaration.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below